US Federal Senate Bill SR299

US Federal 2025-2026 Regular Session

• Introduced: 6/24/25

Caption

A resolution expressing support for the designation of July 2025 as "National Sarcoma Awareness Month".

Summary

S. Res. 299 is a simple Senate resolution expressing support for designating July 2025 as National Sarcoma Awareness Month. The resolution recites background information about sarcoma, describing it as a rare cancer of the bones and connective tissues that can occur in many parts of the body. It notes estimated U.S. incidence and mortality figures, the number of people living with the disease, the fact that sarcoma represents a small share of adult cancers but a larger share of childhood cancers, and that there are more than 70 identified subtypes. The resolution also highlights that the causes of sarcoma are not well understood and that treatment may include surgery, radiation therapy, or chemotherapy. It states that sarcoma is often misdiagnosed and underreported, and it frames the awareness month as a way to improve public understanding and encourage earlier and more accurate diagnosis and treatment. The measure is declaratory rather than regulatory: it does not create a new program, mandate spending, or amend existing health statutes.

Impact

This resolution has no direct legal or regulatory effect on state law or federal statutory requirements. Its practical impact is symbolic and educational, supporting public awareness efforts around sarcoma and potentially encouraging advocacy, screening awareness, and patient education. Because it is a Senate resolution, it does not change benefits, coverage, reporting rules, or treatment standards for patients, providers, or insurers.

Sentiment

The sentiment around the bill appears strongly supportive and noncontroversial. It was agreed to by unanimous consent, without amendment and with a preamble, indicating broad bipartisan acceptance and no recorded opposition. The resolution’s focus on a rare and serious cancer, along with its awareness-oriented purpose, likely contributed to the positive reception.

Contention

There is little to no visible contention in the available record. No votes were recorded and no committee debate transcripts were provided, suggesting the measure moved without substantive dispute. The only potentially debatable aspect is that the resolution is purely commemorative and does not provide funding or policy changes, but that does not appear to have generated opposition in this case.